Considering that dolichol phosphate mannose has different expression patterns in multiple cancer types, such as glioma and head and neck cancer, we can regard the APA status of DPM2 as a potential biomarker for the identification of different tumor types [43]. This evidence concerns the gene DPM2 and central nervous system cancer.